Permira Targets Over $15bn for New Flagship Fund

Permira Targets Over $15bn for New Flagship Fund

Permira is targeting more than $15bn for a new private equity fund less than two years after raising its last flagship investment vehicle, according to people familiar with the matter. The buyout firm is in the early stages of speaking with investors about the...
Private Equity Firm to Buy UDG Healthcare in $3.7bn Deal

Private Equity Firm to Buy UDG Healthcare in $3.7bn Deal

Private equity firm Clayton, Dubilier & Rice has agreed to buy London-listed UDG Healthcare for $3.7bn, the pharmaceuticals services company said on Wednesday. CD&R will pay about $14.46 in cash per share in UDG, a premium of 21.5% on Tuesday’s close. UDG,...